ArticlePsychopharmacology2025
The effect of sertraline on depressive symptoms and serum inflammatory factors in adolescent with depression.
Article in Psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Repurposing Selective Serotonin Reuptake Inhibitors as Immunomodulators: Effects on Macrophage Activation and Polarization.Molecular neurobiology · 2026Review
- Sertraline and inflammatory markers in major depression: a systematic review and meta-analysis.Annals of general psychiatry · 2025Review
- Role of depression-mediated alterations in pro-inflammatory cytokines in carcinogenesis.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveInvestigating the effects of sertraline on depressive symptoms and serum inflammatory factors in adolescents with depression to verify the relationship between depressive state and serum inflammatory factors.
methodsRetrospective collection was conducted on 50 adolescent depression patients treated with sertraline admitted to a hospital from January 2021 to December 2022 as the observation group. By propensity score matching, 50 non pharmacological adolescent depression patients were matched as a control group in a 1:1 ratio. Kutcher Adolescent Depression Scale (KADS-11) scores were retrospectively analyzed before treatment (T1) and on 8th week after treatment (T5). At the same time, the scores of interleukin-1β (IL-1β), interleukin-2 (IL-2), interleukin-11 (IL-11) scores, and interleukin-2 (IL-6), as well as tumor necrosis factor - α (TNF-α) before treatment (T1), on 1st week (T2), 2nd week (T3), 4th week (T4), and 8th week (T5) of the two groups were also retrospectively studied. Pearson correlation analysis was used to verify the relationship between depressive symptoms and serum inflammatory factors in adolescents with depression. Multiple linear regression analysis was used to find out the effect of serum inflammatory factors on depressive symptoms in adolescents with depression.
resultsAttention problems, body discomfort, and total score of KADS-11 in control group were significantly decreased compared with those before treatment at T5 (P < 0.05). Every score and total scores of KADS-11 in observation group were significantly lower than those before treatment (P < 0.05), and the data in observation group were lower than those in control group (P < 0.05). According to repeated measurement ANOVA, there were statistically significant differences in IL-1β, IL-2, IL-6, and TNF-α levels between the two groups (P < 0.05), and the change of serum inflammatory factors in the observation group was more obvious than that in the control group. Pearson correlation analysis showed that the total scores of KADS-11 were positively correlated with serum inflammatory factors (r = 0.881 ~ 0.932, P < 0.05). Linear regression analysis showed that IL-1β, IL-2, IL-6, and TNF-α had positive effects on the total score of KADS-11 (B = 0.145-0.444, P < 0.05).
conclusionSertraline can effectively relieve the symptoms of depression in adolescents and reduce inflammation. Serum inflammatory factors have a significant relationship with depressive symptoms, so it can be considered as an evaluation index of treatment effect.
Indexed as
Identifiers
40526303What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.